BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Cornerstone Therapeutics Inc. 

2000 Regency Parkway
Suite 255
Cary  North Carolina  27518  U.S.A.
Phone: 888-466-6505 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Cornerstone Therapeutics Inc. Stockholders Approve Merger 2/4/2014 10:02:19 AM    More...
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014 9:58:06 AM    More...
Cornerstone Therapeutics Inc. Adjourns Special Meeting of Stockholders 2/3/2014 10:21:32 AM    More...
Cornerstone Therapeutics Inc. Launches BETHKIS(R) (Tobramycin Inhalation Solution) For Management Of Cystic Fibrosis Patients With Pseudomonas Aeruginosa 11/21/2013 11:08:52 AM    More...
Cornerstone Therapeutics Inc. Reports Third Quarter 2013 Financial Results 11/8/2013 9:11:04 AM    More...
Cornerstone Therapeutics Inc. Announces Initiation of Phase 2 Clinical Trial of CPI-613 for the Treatment of Small Cell Lung Cancer 10/24/2013 9:40:12 AM    More...
Chiesi Farmaceutici SpA to Buy Rest of Cornerstone Therapeutics Inc. for $255 Million 9/16/2013 6:52:01 AM    More...
Cornerstone Therapeutics Inc. Initiates PERTZYE® (pancrelipase) Sales and Marketing Efforts for the Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis 7/30/2013 8:45:59 AM    More...
Cornerstone Therapeutics Inc. Sues to Enforce Its CARDENE(R) I.V. Patents 7/25/2013 10:04:50 AM    More...
Cornerstone Therapeutics Inc. Receives CARDENE(R) I.V. (Nicardipine Hydrochloride) Paragraph IV Notice Letter 6/13/2013 10:04:55 AM    More...
12345678910

//-->